TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Goal Attainment Scale (GAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of postoperative negative behavior changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Immunological non-inferiority
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sino-Nasal Outcome Test (SNOT)-22 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to the first recurrence of chronic bacterial cystitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Hematological tests WBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Hematological tests Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Negative Automatic Thoughts
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average daily hours of hearing aid use
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Manual Classification Scale of Ability (MACS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Carbohydrate Malabsorption as measured by patient symptom survey
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Carbohydrate Malabsorption as measured by growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Carbohydrate Malabsorption as measured by enteral nutrition tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Quality of Life Enjoyment and Satisfaction Questionnaire, short version (Q-LES-Q-SF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fracture Union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 Hospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: Visual Analogue Scale (VAS) of global anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of treatment emergent and treatment related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease of stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ICM System-related Complication-free Rate at 30 Days Post-implant
Endpoint domain: Adverse events/effects
Primary endpoint: ICM System-related Complication-free Rate at 12 Months Post-implant
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants who are UTI-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of patients presenting new metastatic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: sensitivity/specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: negative predictive value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expression levels of circANKRD36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target Area Non-vellus Hair count change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Fitness Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with VL below 20 copies/ml in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with a CD4 count higher than 200 cells/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Distance from alveolar bone crest to the cemento-enamel junction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from cemento-enamel junction to the gingival margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cemento-enamel junction identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psoriasis Area and Severity Index (PASI) Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Event (AE) / Serious Adverse Event (SAE) Incidence Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in speech perception performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in communication function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who reported an adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with prescribed medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessments of meaningful clinical effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meaningful improvement in functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assisting Hand Assessment Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Box and Blocks Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9-Hole Peg Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade of Emergence cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants reporting medically attended adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Obesity Related Comorbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of taste problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of taste problems on dietary intake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact of taste problems on quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Muscle sympathetic nerve activity (MSNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cognitive performance via Stroop Color and Word Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cognitive performance via NIH Toolbox Cognitive Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visuo-tactile performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiving composite questionnaire (CCQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent Development Interview-Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of multidrug resistant tuberculosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Multi-target hepatocellular carcinoma panel (MHP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence and number of prostate tumour cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Expiratory Reserve Volume (ERV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Critical Closing Pressure (Pcrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acceptable safety outcomes (Serious Device and/or Procedure Related Events)
Endpoint domain: Adverse events/effects
Primary endpoint: Technical success defined as <30% residual stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in [18F]FNP-59 chemistry uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Athlete Disability Index Questionnaire (ADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Parental mental health: anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental mental health: depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental mental health: perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale for Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Wong-Baker FACES pain rating scale (WB-FACES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of Postoperative Nausea and Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Fugl Meyer Upper extremity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wolf Motor Function Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Examination of muscle thickness by ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: seroprotection rate of 13 vaccine serotype-specific pneumococcal IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of all serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: sensitivity and specificity of serum ferritin in the diagnosis of irAE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DN 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean overall IDEEL-Symptom Bother (SB) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Resultant overall CLDEQ-8 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of Postoperative Urinary Tract Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in CDR-SB total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Objective Response Rate (ORR) in patients with FGFR2 fusions who have failed at least one previous treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) in patients with FGFR2 fusions who have responded on at least one previous treatment and discontinued due to progressive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) in patients with FGFR alterations other than FGFR2 fusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) in patients without FGFR alterations (wild-type FGFR mutation status)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digestive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants with Venous thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Immediate reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Total physical activity (vector magnitude) per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants that complete at least six Sprint Interval Training (SIT) sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of Ergometer (ERGO) sessions that participants complete between treatment completion and 6 month follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroop Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tolerability of RIC
Endpoint domain: Adverse events/effects
Primary endpoint: Gist Comprehension of Genetic Cancer Risk
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Knowledge of Cancer Screening
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Psychosocial Aspects of Hereditary Cancer (PAHC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Distress Thermometer (DT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Interval from induction to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change on Perceived Stress Scale 4 (PSS-4)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change on Brunnsviken Brief Quality of Life Scale (BBQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in baseline faecal calprotectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CTCAE level 3 toxic reaction ratio
Endpoint domain: Adverse events/effects
Primary endpoint: CTCAE level 4 and 5 toxic reaction ratio
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of individuals with cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy on Referent Selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy on Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Drinks Per Occasion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Inter-rater reliability of Internal Jugular Vein Ultrasound measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Dental Anxiety Scale (MDAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Variation in Anxiety VAS (VAS-A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Asymptomatic hyperuricaemia detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Scaling operation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year Disease-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Lens stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glaucomatous damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Growth Tracking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SctO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BETY-Biopsychosocial Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: discharge times
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Carbon Monoxide Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to Substitute from Cigarettes to ENDS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective Response Rate (mRecist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of nociception indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Ranking Scale (mRS) score at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in fatigue - BFI
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in fatigue - FACIT-F
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: In-hospital opioid use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post-discharge opioid use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants with NAFLD Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Caregiver Strain Index (CSI)
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Rate of radiation-induced pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of radiation-induced esophagitis
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of myelosuppression
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of bacterial infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of Radiographic Progression-Free Survival (rPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Affection of tracheo-esophageal fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum tolerated dose (MTD) or Dose-limiting toxicity (DLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Concentration-time Curve From Time of Dosing to the Last Measurable Concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-op Pain Scores During Initial Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-op Narcotic Pain Medication Use During Hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Effectiveness of V-NAV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in plasma estradiol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in plasma PrEP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in intracellular PrEP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Morbidity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle belly length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tendon length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fascicle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of 68Ga-tilmanocept PET/CT for SLN mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients undertaking a 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At least 50% reduction in PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: At least 50% reduction in DLQI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Composite of all-cause death and hospitalization for worsening heart failure
Endpoint domain: Mortality/survival
Primary endpoint: taste disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of snatch repetitions performed to exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in MRI imaging of Graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Quadriceps Volume & Cross-sectional Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Difference in Thigh Circumference Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: keratinized tissue height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucosal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MCG to detect coronary lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of MCG to detect myocardial necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progression based on microbiome analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alternate hand-wall toss test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core muscle endurance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported testing for Malaria and HIV
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Heavy Drinking Days (Binge drinking)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the brief alcohol intervention, as measured with mHIST
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe neurological failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wong-Baker Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allergen-specific IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time till home readiness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Conditioned Pain Modulation (CPM) Profile (Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conditioned Pain Modulation (CPM) Profile (Heat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Offset Analgesia (OA) Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporal Summation (TS) Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes